Logo

Marksans Pharma Ltd. Share Price

Marksans Pharma Ltd. (INR)257.99.4   (3.8%)

Exchange ScripsBSE524404NSEMARKSANSISININE750C01026

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Marksans Pharma Ltd. Performance

Market performance
Open price250
High260.5
Volumes1043044
Prev Close257.9
Low248.75
Closing date2025-01-14
Historical performance
1 Year High358.70
3 Year High358.70
5 Year High358.70
1 Year Low130.00
3 Year Low38.60
5 Year Low9.85

Marksans Pharma Ltd. Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
11732
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
37.26
Dividend Yield
Dividend Yield
0.23 %

Marksans Pharma Ltd. Investment Returns

1 Year
58.1%
3 Years
324.5%
5 Years
1243.2%
10 Years
300.5%

Marksans Pharma Ltd. Technicals

IndicatorsValueSignal
5-DMA264.97Bearish
10-DMA280.09Bearish
20-DMA291.2Bearish
50-DMA307Bearish
100-DMA291.35Bearish
200-DMA232.26Bullish

Shareholding Pattern

FieldDec-2024Sep-2024Jun-2024Mar-2024Dec-2023
Promoters22222
Foreign Investors---------------
Domestic Investors22222
Public Investors259811248843235498254697237375
Government---------------

Marksans Pharma Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income50459341967
Operating Profit5090398630073463
Interest112918480
Depreciation743519448362
Profit Before Tax4235337724753022
Consolidated Net Profit3137266318462359
Adjusted EPS7656

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital453453409409
Total Reserves2019716998106828456
Minority Interest209199207189
Total Non-Current Liabilities2052843571237
Total Liabilities26810219041660112280
Capital Work in Progress5472756
Total Assets26810219041660112280

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities230423749931786
Cash Flow from Investing Activities-1408-2592-844-448
Cash Flow from Financing Activitie-6871978795-153
Net Cash Inflow / Outflow20817609441185
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 37.26.
  • 3Y Stock Price CAGR of the stock is 61.9.
  • The stock has a beta of 1.0.
  • In the last financial year, the company had an EBITDA of ₹5090 Million.
  • The company generated revenue of ₹21774 Million in the previous financial year.

Marksans Pharma Ltd.

257.99.4   (3.8%)

Investment Amount: ₹ 16075
Current Value: ₹ 25790
Performance: 60.4%
P/L: ₹ 9715
Top Gainers
SymbolChange%
BRNL47.17(20%)
SURYAROSNI280.05(20%)
ADANIPOWER537(19%)
KHANDSE29.12(19%)
IOB53.77(18%)
Top Losers
SymbolChange%
SABTNL845.05(-10%)
HCLTECH1813.55(-9%)
DNAMEDIA5.8(-8%)
KFINTECH1172.2(-7%)
PRSMJOHNSN152.92(-6%)
YAARI13.88(-5%)
TVVISION12.77(-5%)
UNITDSPR1407.25(-5%)
Similar stocks

Zota Health Care Ltd.

44.3

989.5

December 14 - January 14

Bajaj Healthcare Ltd.

29

545

December 14 - January 14

Medico Remedies Ltd.

23.6

61.98

December 14 - January 14

Brooks Laboratories Ltd.

15.9

174.84

December 14 - January 14

Blue Jet Healthcare Ltd.

15.8

581.4

December 14 - January 14

Concord Biotech Ltd.

10.2

2327.4

December 14 - January 14

Biocon Ltd.

9.9

387.65

December 14 - January 14

Gufic Biosciences Ltd.

8.8

469.5

December 14 - January 14

Announcing Stock of the Month!

Stock of the Month
Stock of the Month